Sponsored by bioMerieux Canada Inc.

This project is designed to recognize and encourage scientific contributions to the study and advancement of syndromic testing of infectious diseases in Canada. The recipient of this award will receive a $5,000 prize and will be invited to give an oral presentation of their work at the annual AMMI-CACMID meeting.

 

Eligibility

Eligibility and Selection Criteria:

  • Candidates must be current CACMID members.
  • Candidates must be investigators of Syndromic Infectious Disease Testing. Appropriate research in this field may be based on antimicrobial stewardship, clinical outcomes, and/or laboratory investigations. Preference will be given to investigators who seek to include patient-important outcomes in their research, and/or go beyond simple diagnostic evaluations of test performance.
  • Candidates should be either the first or last author of at least one paper or poster with a focus on Syndromic Infectious Disease Testing published in a peer-reviewed scientific journal or presented at a respected scientific meeting within the last 2 years (papers/posters may be in press or accepted for publication/presentation).
  • Previous contributions and track record of activity in this field will also be taken into consideration.
  • Candidates can only receive the award once.

Application Procedure

  • Complete applications must be received by January 23, 2019.
  • Submit complete application by email to awards@cacmid.ca.
  • Each application should include:
    • Curriculum vitae
    • Complete list of publications / posters
    • Copy of original paper(s) or poster(s) which contribute to the study of Syndromic Infectious Disease Testing (may be published or accepted for publication)
    • One-page summary describing the significance of the work and how it contributes to the topic of Syndromic Infectious Disease Testing
  • Incomplete applications will not be considered.

Award Announcement:

  • Successful applicants will be contacted in March 2020.
  • Awardees will present their research at the annual AMMI-CACMID meeting.